Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Bangalore(1)
- Mumbai(8)
- Gujarat(10)
- Maharashtra(5)
- Pune(3)
- Ahmedabad(3)
- Hyderabad(8)
- Karnataka(2)
- Delhi(1)
- Tamil Nadu(1)
- Nagpur(2)
- Punjab(1)
- Telangana(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.96%
- 99.95%
- 99.91%
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.42%
- 99.36%
- 99.29%
- 99.18%
- 99.0%
- 99%
- 98.60%
- 98.12%
- 98.0%
- 98%
- 98 %
- 97.57%
- 97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- 95.00%
- >95%
- 95%
- 94.00%
- >92%
- 90%
- >90%
- 90 % Above
- 86.74%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 1and gm
- 1MT
- 250250 mg.
-
N-[[(HEXAHYDROCYCLOPENTA [C]PYRROL-2(1H)-YL)AMINO]CARBONYL]-2-METHYL BENZENESULFONAMIDE
1076198-18-9
-
Gliclazide EP Impurity G
-
SulfaMethoxazole Related CoMpound F
17103-52-5
-
Prostaglandin iMpurity F -
Sitagliptin Impurity 27
1608491-98-0
-
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED
911661-90-0
-
Valproic Acid IMpurity F
-
Lacosamide Related Compound F (30 mg) (2-Acetamido-N-benzyl-3-hydroxypropanamide)
171623-02-2
-
Aceclofenac Benzyl Ester
100499-89-6
-
Lincomycin EP Impurity F
14810-93-6
Gliclazide impurity-F 1076198-18-9
SITAGLIPTIN IMPURITY F 1608491-98-0
98% Granisetron EP Impurity-5, OR Impurity F, 25mg 1364914-39-5
98% Clarithromycin Impurity F, 25mg, Lab Grade 128940-83-0
Dibenzo[b,f][1,4]-thiazepin-11(10H)-one 3159-07-7
Irinotecan Impurity L (HCl Salt) 1992961-26-8